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ABSTRACT 
Malaria is a tropical infectious disease with high morbidity and mortality rates. In malaria, various kinds 
of haematological complications can arise, one of which is thrombocytopenia. Thrombocytopenia is most 
commonly encountered during acute malaria infection with varying degrees observed in both Plasmodium 
falciparum and Plasmodium vivax infections. The purpose of this study was to determine the relationship 
between the types of Plasmodium falciparum and Plasmodium vivax with the degree of thrombocytopenia 
in malaria patients at the Ratu Aji Putri Botung Penajam Paser Utara Hospital. This research is an 
observasional analytic study with cross sectional method. The data was taken by using purposive 
sampling method from the medical records of malaria patients hospitalized in Ratu Aji Putri Botung 
Penajam Paser Utara Hospital in the period of January 2013 - August 2018.  Data analysis used the Chi-
square test. Of the 310 malaria patients who were study subjects, 60,3% (n = 187) were infected with 
Plasmodium falciparum and 39,7% (n = 123) were infected with Plasmodium vivax. Most of the research 
subjects were male (95,8%) who were dominated by adults (56,5%). As many as 90% of malaria patients 
experienced thrombocytopenia with mild, moderate, and severe thrombocytopenia respectively 29,4% ; 
56,6% ; 14,0%. Severe thrombocytopenia was more common in falciparum malaria patients (16,4%). The 
statistical test result for the type of Plasmodium with the degree of thrombocytopenia were p = 0,139. It 
was concluded that there was no relationship between the types of Plasmodium falciparum and 
Plasmodium vivax with the degree of thrombocytopenia in malaria patients.  
Keywords: Malaria, Plasmodium, Degree of Thrombocytopenia 
 
INTRODUCTION 
   The term malaria comes from two Italian words, namely “mala” means bad and “aria” means 
air because at that time this disease was often found in swampy areas that emitted a foul smell into the air 
in Rome. 1 The disease is caused by intracellular obligate protozoa in the blood of the genus Plasmodium. 
In humans, there are 5 types of Plasmodium that can cause malaria : Plasmodium falciparum, 
Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, and Plasmodium knowlesi. 2  
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 Malaria is mostly a health problem in tropical and subtropical regions, especially countries in 
Africa and Asia. 3 World Malaria Report 2019 estimates that there were 228 million cases and 405.000 
deaths related to malaria in the world in 2018. 4 Meanwhile, Penajam Paser Utara is the only area with 
high level of malaria endemicity outside the eastern region of Indonesia which is located in the Province 
of East Kalimantan. 5  
 In malaria patients, there are frequent changes in their haematological status including anemia, 
thrombocytopenia, and leucopenia to leukocytosis as a result of the activity of the malaria parasite. 6  
Thrombocytopenia is a condition in which the platelet counts is less than 150.000/µl of blood. 7  
Thrombocytopenia is the most common haematological complication of malaria, especially in 
Plasmodium falciparum and Plasmodium vivax infections. So that some literature makes 
thrombocytopenia which is accompanied by fever, as an early indicator to increase the suspicion of an 
acute malaria diagnosis and lead to other, more specific check-up. 8-10  In general, thrombocytopenia in 
malaria is mild to medium and rarely symptomatic. 8,9  However, the emersion of severe 
thrombocytopenia needs to be watched out because it is a good predictor of a bad prognosis so that the 
effective management is needed to prevent complications that may arise. 9  One study stated that there 
was a 2.4-fold increased risk of hospitalized  and a 4.7-fold increased risk of death in malaria patients 
with severe thrombocytopenia. 11  
 The main mechanism of thrombocytopenia is not known for sure, but platelet damage caused by 
immunological and non-immunological processes is presumed to play a role in the occurrence of 
thrombocytopenia in malaria. 9  Several studies have also linked between thrombocytopenia to the 
infecting Plasmodium species. Devineni et al., (2015) found that Plasmodium falciparum infection often 
caused a decrease in amount of platelet to a severe degree than Plasmodium vivax infection, whereas 
another study by Kochar et al., (2010) found the opposite. 12.13  
                                     
MATERIAL AND METHOD 
This type of research is an analytic observational study to find the relationship between two 
variables with a cross sectional design. Sampling was done by purposive sampling. The sample of this 
study were all malaria patients at the Ratu Aji Putri Botung Penajam Paser Utara Regional Hospital for 
the period January 2013 to August 2018 who met the inclusion and exclusion criteria of the study. The 
inclusion criteria of this study were patients diagnosed with malaria by an internist through confirmation 
of microscopic examination and undergoing hospitalization, and the results of routine blood tests at the 
time of arrival in the form of platelet counts. The study exclusion criteria were patients with mixed 
malaria, being pregnant, having other diseases that could affect routine hematological examinations such 
as chronic liver disease, bleeding disorders, HIV / AIDS, dengue hemorrhagic fever, chronic renal failure, 
malignancy, and patients who had received an anti-malaria treatment regimen before blood tests. Data 
sourced from the medical records of inpatient malaria patients at the Medical Record Installation of the 
Ratu Aji Putri Botung Penajam Paser Utara Hospital. 
 The independent variable of this study was the type of Plasmodium that causes malaria, namely 
Plasmodium falciparum and Plasmodium vivax. The dependent variable is the degree of 
thrombocytopenia. The degree of thrombocytopenia is grouped into three degrees, namely mild degrees 
(100,000 - 150,000 / µl), moderate degrees (50,000 - 100,000 / µl), and severe degrees (<50,000 / µl). The 
data were then analyzed by univariate and bivariate. Bivariate analysis was tested by Chi-square and was 
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considered significant if the p value was <0.05. The study was approved by the Health Research Ethics 
Commission of the Faculty of Medicine, Mulawarman University No. 13 / KEPK-FK / VIII / 2020. 
 
 
RESULTS AND DISCUSSION 
In this study, 310 patients became the research sample obtained from the medical record 
data of malaria patients at the Medical Record Installation of the Ratu Aji Putri Botung Penajam 
Paser Utara Hospital. The results of the univariate analysis of this study are shown in Table 1. 
Tabel 1. Characteristics of Malaria Patients at Ratu Aji Putri Hospital, Botung Penajam Paser 

















The majority of malaria patients at Ratu Aji Putri Botung Penajam Paser Utara hospital were 
infected with Plasmodium falciparum (60,3%) followed by Plasmodium vivax infection (39,7%). 
Similar to research by Dini et al., (2020) in Papua, where the most species that cause malaria is 
Plasmodium falciparum (54,4%) followed by Plasmodium vivax (32,5%). 14  The similar results 
were also reported by Patel et al., (2012) in Gujarat India, as many as 59% of malaria patients 
were infected with Plasmodium falciparum and 41% were infected by Plasmodium vivax. 15  In 
contrast to the study by Kustiah, Adrial, and Reza (2020) in Padang, West Sumatra, where the 
majority of malaria patients were infected with Plasmodium vivax (85%) compared to 
Plasmodium falciparum (13,3%). 16  
Differences in species that predominantly infect the population in an area can occur due to 
differences in geographical and ecological conditions for the breeding grounds for Plasmodium 
and Anopheles mosquitoes even though they are in the same country. 17  The high number of P. 
falciparum infection cases in the population in the Penajam Paser Utara area is in line with the 
report of the Indonesian Ministry of Health (2018), where 52% of malaria cases in Indonesia are 
caused by P. falciparum species infection. 5  The majority of malaria patients in this study were 
male (95.8%). This result is similar to research by Devineni et al., (2015) which states that the 
Characteristics Percentage (%) Frequency (n) 
Plasmodium type   
  P. falciparum 60,3 187 
  P. vivax 39,7 123 
Sex   
  Male 95,8 297 
  Female 4,2 13 
Age (year)   
  0 – 5  0,3 1 
  6 – 11 1,0 3 
  12 – 25 30,6 95 
  26 – 45 56,5 175 
  46 – 70  11,6 36 
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percentage of male malaria patients is greater, namely 75.6% compared to female malaria 
patients, which is only 24.4%. 12  Similar results were also reported by Ghanchi et al., (2019) 
where 70.4% of malaria patients were male and 29.6% of female malaria patients. 18  
 Men are more at risk of getting malaria because it is associated with high activities 
outside the home such as working. 16  The dominance of the types of work in the forestry, 
agriculture and fisheries sectors in the Penajam Paser Utara region also explains why malaria 
cases in male patients are so high in this region. 19 This is because their working environment is 
an ideal habitat for Anopheles mosquitoes to live and breed. 20 Women spend more time in the 
house doing household chores and their way of dressing is more closed than men so they have 
less contact with vectors. 21,22 The difference in malaria morbidity between men and women is 
also influenced by hormonal and genetic factors, where men produce chemicals that are more 
attractive to mosquitoes and the testosterone is known to suppress the anti-plasmodial immune 
response, on the other hand, the female hormone estrogen has been shown to increase the anti-
plasmodial immune response. 22,23  
 Table 1 shows that most of the malaria patients in the Ratu Aji Putri Botung Regional 
Hospital are in the age range 26 - 45 years (56.5%). This result is similar to Surve et al., (2017) 
in India, where 57% of malaria cases were in the 21-40 year age group. 24  Similar results were 
also reported by Afdhal et al., (2014) in West Sumatra where the majority of malaria patients 
were in the 20-40 year age group (44.8%). 6 High cases of malaria in the productive age group 
are related to their high mobility outside the home such as working, changing workplaces, or 
even traveling to malaria endemic areas, where this situation further increases their chances of 
contact with malaria vectors. 16,20,21 The high number of productive age malaria cases in Penajam 
Paser Utara is related to the working age of the population in this region, where the majority are 
in the age range 15 - 44 years. 19  
 
Table 2. Relationship between P. falciparum and P.vivax types with the degree of 




Degree of Thrombocytopenia P value 
Mild(%) Moderate(%) Severe(%)  
P. falciparum 44(25,7) 99(57,9) 28(16,4)  
0,139 P. vivax 38(35,2) 59(54,6) 11(10,2) 
Jumlah 82(29,4) 158(56,6) 39(14,0) 
 
 Based on table 2, moderate thrombocytopenia was found mostly in both types of 
Plasmodium infections (56.6%). Mild thrombocytopenia was more common in vivax malaria 
patients (35.2%) and severe thrombocytopenia was more common in falciparum malaria patients 
(16.4%). This result is similar to the research by Siagian et al., (2018) in East Kalimantan which 
found that 87% of malaria patients experienced thrombocytopenia with moderate 
thrombocytopenia occupying the largest percentage (45.65%). 7  Similar results were also 
obtained by Punnath et al., (2019) in Mangaluru India, of 627 malaria patients, 78.6% of them 
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experienced thrombocytopenia which was dominated by moderate thrombocytopenia (32.7%). 25 
However, different results were reported by Bakhubaira (2013) in Yemen where mild 
thrombocytopenia was found to dominate in the amount of 57.6% followed by moderate 
thrombocytopenia at 24.2%. 26  
Thrombocytopenia in malaria is generally mild to moderate and is rarely symptomatic. 8,9 
However, the emerge of severe thrombocytopenia needs to be watched out because it is a good 
predictor of poor prognosis. 9 The main mechanism of thrombocytopenia in malaria is not fully 
understood. 27-30 However, researchers hypothesized mechanisms that might play a role include 
coagulopathy,  platelet sequestration in the spleen, platelet aggregation, immune-mediated 
platelet destruction, changes in bone marrow leading to impaired platelet production, oxidative 
stress, or perhaps even P.falciparum-induced peripheral destruction. 27,28,30  
During acute malaria infection, thrombocytopenia is associated with an increase in 
platelet-associated IgG (PAIgG). These antibodies can activate platelets by binding to parasite 
antigens attached to the platelet surface and forming immune complexes in situ and triggering 
platelet lysis. 9,31,32 Binding of platelets with PAIgG can also lead to removal of platelets by the 
reticuloendothelial (spleen) through phagocytosis of activated macrophages. 31 Hemolyzed 
infected erythrocytes produce adenosine diphosphate (ADP), a proaggregation factor that can 
play a role in triggering platelet activation and aggregation responses. 9,31  Platelet adherence and 
aggregation in malaria has also been associated with increased von Willebrand factor (vWF) 
levels and ADAMTS13 deficiency. 31,33 This results in an increased use of platelets which results 
in peripheral thrombocytopenia.31 Macrophages are thought to play a role in causing 
thrombocytopenia in malaria. 31 In clinical trials of recombinant macrophage colony stimulating 
factors (M-CSF) it was found that an increase in M-CSF can trigger an increase in platelet 
destruction through increased macrophage activity. 8,32 
 Platelet breakdown through oxidative stress is also known to be involved in the 
etiopathogenesis of thrombocytopenia. This is based on the finding of low levels of platelet 
superoxide-dismutase followed by an increase in gluthathione-peroxidase activity and high 
levels of platelet lipid peroxidase in malaria patients compared to healthy people. 32 In acute 
malaria infection, platelets are found to be more hypersensitive. 9,27 This is influenced by various 
factors such as immune complexes, the surface of the platelets in contact with infected 
erythrocytes, and damage to endothelial cells. 9 In addition, it was also found that there was an 
increase in the concentration of specific platelet-related proteins such as platelet factor 4 (PF4), 
beta thrombo-globulin (βTG), as well as an increase in the production of thromboxane A2 and 
prosycline. 27 This hypersensitivity of platelets is postulated to increase the hemostatic response 
and is the reason why bleeding is rare even in significant thrombocytopenia. 9 
 Cytokines released during the inflammatory response of malaria are known to contribute 
to the severity of thrombocytopenia. 25  This situation is associated with increased levels of 
several cytokines such as TNF-α, IFNγ, IL-12, and IL10. Increased levels of TNF-α in malaria 
infection can play a role in the emergence of thrombocytopenia through trapping mechanisms 
and consumption of platelets in inflamed blood vessels. 25,34  IL-10 is an anti-inflammatory 
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cytokine as well as an immunoregulator that can suppress the production of pro-inflammatory 
cytokines by suppressing the activity of NK cells, macrophages, and Th-1. However, the 
presence of these cytokines can suppress platelet production. On the other hand, IL-6 is 
associated with its role in platelet production by promoting megakaryotopoiesis. 29  However, it 
is known that there is a decrease in plasma levels of these cytokines during severe 
thrombocytopenia. 25  
Based on table 2, the results of data analysis with the Chi-square test obtained p value = 
0.139 (p > 0.05), which means there is no relationship between the types of Plasmodium 
falciparum and Plasmodium vivax with the degree of thrombocytopenia. These results are similar 
to a study by Martínez-Salazar & Tobón-Casta (2014) in Colombia of 862 malaria patients. The 
study showed that severe thrombocytopenia was found in 10.3% of falciparum malaria patients, 
10.9% in vivax malaria patients, and 22.2% in mixed infections. The results of statistical analysis 
did not show an association between the type of Plasmodium infection and the severity of 
thrombocytopenia (p > 0.05). The study also stated that the platelet count did not differ based on 
the type of infecting species, indicating that there was a similar pathomechanism between 
Plasmodium falciparum and Plasmodium vivax infections. 35  
However, the results of this study are not in line with research by Arif et al., (2016) in 
India which states that there is a significant relationship between the types of Plasmodium 
falciparum and Plasmodium vivax with the degree of thrombocytopenia (p <0.001). In that study, 
mild thrombocytopenia was generally associated with Plasmodium vivax (52.8%) than 
Plasmodium falciparum infection (10.71%), whereas severe thrombocytopenia was more 
common with Plasmodium falciparum infection (46.43%) than Plasmodium vivax infection ( 
8.34%). 21 Although the results of this study statistically did not show a relationship between the 
types of infected species and the degree of thrombocytopenia, this study found that Plasmodium 
falciparum infection caused more severe thrombocytopenia when compared to Plasmodium 
vivax infection (16.4% vs 10.2%). This is not surprising given that malaria infection by 
Plasmodium falciparum is often associated with severe malaria pathogenesis. 36  
Plasmodium falciparum has the ability to modify the surface of infected erythrocytes so 
that they appear knobs. 37 In this knob, various kinds of proteins are expressed that can bind to 
surrounding erythrocytes, especially uninfected erythrocytes, blood vessel endothelium, and 
platelets. One of the proteins that play an important role in sitoadherens is Plasmodium 
falciparum Erythrocyte Membrane Protein (PfEMP-1) which can bind to several receptors, one 
of which is the CD36 receptor in the endothelium and platelets. The CD36 receptor which is 
expressed by platelets itself has a major role in mediating the clotting of parasite-infected 
erythrocytes. 31 The main proportion of total platelets in malaria patients is found in the platelet-
erythrocyte complex so that this condition contributes greatly to the occurrence of 
thrombocytopenia. 38  
In India, Punnath et al. reported that there was an increase in levels of cytokines TNF-α 
and IL-10 and insignificant changes and even tended to decrease IL-6 levels in patients with 
falciparum malaria who experienced thrombocytopenia when compared to patients with vivax 
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malaria. These cytokines are known to play a role in the severity of thrombocytopenia during the 
malaria inflammatory response. 25 A meta-analysis study conducted by Naing & Whittaker 
(2018) actually found that vivax malaria patients and even severe falciparum malaria patients 
had the same risk of developing severe and even very severe thrombocytopenia. 28 Research by 
Dayanand et al., (2019) showed that there was no significant difference in platelet counts 
between falciparum malaria patients and vivax malaria sufferers. 39 This suggests that the two 
types of Plasmodium species have an equal chance of causing a decrease in the number of 
platelets. 
In other studies that analyzed the relationship between Plasmodium type and the degree 
of thrombocytopenia, there was often a significant relationship, but in this study, the results were 
not related. This can occur considering that clinical manifestations in malaria patients can be 
influenced by various factors such as host factors, parasitic factors, and environmental factors. 
The clinical manifestations between individuals can be very diverse, ranging from asymptomatic 
malaria to severe and deadly malaria. The difference in morbidity patterns is thought to be 
related to the age of the host, the cumulative exposure of parasite clones with different virulence, 
to the host's immunity and genetic polymorphisms which ultimately determine the onset of 
severe malaria symptoms, including thrombocytopenia. Whereas in parasites, factors believed to 
play a role include resistance to antimalarial drugs, the ability of parasites to avoid immune 
responses through antigenic variation and polymorphism, parasite multiplication rates, 
sitoadherens and rosetting, and malaria toxins. 40 
The difference in these results with other studies is also thought to be due to variations in 
the time of infection onset with the patient arrival time to health facility. In a study conducted by 
Hasugian et al., (2018) in Timika Papua, found that the incidence of thrombocytopenia in 
malaria patients began to occur within 1-7 days after illness. 34 Another study even reported a 
decrease in platelet counts that occured within 7-9 days after being bitten by an infected 
Anopheles mosquito. 41 These findings suggest that the longer the time a patient arrives at a 
health facility, the heavier the reduction in platelet counts will be compared to patients who 
arrive earlier since the first onset. The variation in time between infection and arrival to the 
health facility results in variation in the degree of thrombocytopenia despite the infection of the 
same species.  
 
CONCLUSION 
In this study, most malaria patients experienced moderate thrombocytopenia and severe 
thrombocytopenia were more common in patients with P. falciparum infection. The results of 
statistical analysis stated that there was no relationship between P. falciparum and P. vivax with 
the degree of thrombocytopenia. 
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